1. Academic Validation
  2. TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

  • Leukemia. 2020 Sep;34(9):2498-2502. doi: 10.1038/s41375-020-0759-3.
Eva Szenes  # 1 Andrea Härzschel  # 1 2 Sarah Decker 2 Erika Tissino 3 Justine Pischeli 1 Julia Christine Gutjahr 1 Sandra Kissel 2 Sandra Pennisi 2 Jan Philip Höpner 1 Alexander Egle 1 Nadja Zaborsky 1 Christine Dierks 2 Marie Follo 2 Alexandre Chigaev 4 Antonella Zucchetto 3 Richard Greil 1 Valter Gattei 3 Tanja Nicole Hartmann 5 6
Affiliations

Affiliations

  • 1 Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • 2 Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • 3 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • 4 Department of Pathology and Cancer Center, University of New Mexico, Albuquerque, NM, USA.
  • 5 Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria. tanjanhartmann@gmail.com.
  • 6 Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany. tanjanhartmann@gmail.com.
  • # Contributed equally.
Figures
Products